Early Depression Unlikely To Cause More Severe Disability in MS patients, Study Suggests
Researchers have been working on sorting out the causal direction of multiple sclerosis (MS) and depression. These findings suggest that depression can be a consequences of MS-related disability not the other way around.
Researchers Discover Genetic Marker of Severity and Progression in Multiple Sclerosis
Mutations in one locus were associated with a decrease in the median time until needing a walking aid of between 3.3 and 3.7 years.
Health System Specialty Pharmacies Improve IBD Patient Adherence, Reduce Likelihood of ER visits and Hospitalizations, Study Finds
70% of inflammatory bowel disease patients managed by in-system specialty pharmacies were adherent to their therapies, according to research findings.
Encouraging Results Reported with Mirikizumab for Induction and Maintenance Therapy of Moderate to Severe UC
Results reported in the New England Journal of Medicine show that the Eli Lilly drug was superior to placebo in keeping ulcerative colitis in remission.
Study Shows Stopping Disease-Modifying Therapy May Be Safe for Older Adults with MS
The researchers conclude that it is “reasonable option” for older patients with stable multiple sclerosis (MS) to stop taking disease-modifying therapy because the risk of relapse from doing so is small.
Real-world Study Supports Rinvoq as Treatment for Medically Resistant Ulcerative Colitis and Crohn's Disease
The favorable results from the 84-patient study may, in part, depend on some of the definitions used.
2 Clarke Drive Cranbury, NJ 08512